Cargando…
Ibrutinib-Induced Paronychia and Periungual Pyogenic Granuloma
Nail changes elicited by Ibrutinib are relatively infrequent but are reported in the literature. Herein, we report on two cases that developed Ibrutinib-induced nail toxicities. A 63-year-old female, with relapsing mantle cell lymphoma on Ibrutinib 560mg/day for seven months developed paronychia, on...
Autores principales: | Alamri, Awadh, Alghamdi, Yara, Alghamdi, Atheer, Albogami, Dhai B, Shahada, Omar, AlHarbi, Aseel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874258/ https://www.ncbi.nlm.nih.gov/pubmed/36712781 http://dx.doi.org/10.7759/cureus.32943 |
Ejemplares similares
-
Ibrutinib-Associated Multifocal Paronychia with Periungual Pyogenic Granulomas Involving Concomitant Finger and Toe Nails
por: Kaur, Lovleen, et al.
Publicado: (2023) -
Systemic Drug-induced Chronic Paronychia and Periungual Pyogenic Granuloma
por: Wollina, Uwe
Publicado: (2018) -
Recurrent Cutaneous Pyogenic Granuloma of the Nose Following Rhinoplasty: A Case Report
por: Alghamdi Jr., Fareeda S, et al.
Publicado: (2022) -
Topical brimonidine for pyogenic granuloma after paronychia surgery
por: Chen, Yusha, et al.
Publicado: (2020) -
An Uncommon Presentation of Pyogenic Granuloma
por: Luna-Ceron, Eder, et al.
Publicado: (2021)